Windlas Biotech Limited (WINDLAS) — Cash Flow Quality Index
Windlas Biotech Limited (WINDLAS) has a Cash Flow Quality Index of 0.45x as of December 2023. Operating cash flow of Rs67.78 Million is below net income of Rs150.98 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore WINDLAS operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Windlas Biotech Limited Cash Flow Quality Index (2018–2025)
Historical Cash Flow Quality Index for Windlas Biotech Limited across 8 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see Windlas Biotech Limited operating cash flow efficiency.
Annual Cash Flow Quality Index for Windlas Biotech Limited (2018–2025)
Year-by-year earnings quality comparison for Windlas Biotech Limited.
| Year | Quality Index | Operating CF (INR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.12x | Rs681.87 Million | Rs609.94 Million | ▼ -40.3% |
| 2024 | 1.87x | Rs1.09 Billion | Rs581.87 Million | ▲ +75.2% |
| 2023 | 1.07x | Rs609.65 Million | Rs570.39 Million | ▲ +433.4% |
| 2022 | 0.20x | Rs91.30 Million | Rs455.65 Million | ▼ -62.0% |
| 2021 | 0.53x | Rs114.54 Million | Rs217.40 Million | ▼ -48.0% |
| 2020 | 1.01x | Rs250.06 Million | Rs246.68 Million | ▲ +313.6% |
| 2019 | 0.25x | Rs186.54 Million | Rs761.15 Million | ▼ -90.7% |
| 2018 | 2.64x | Rs295.91 Million | Rs111.98 Million | — |